Kyowa Kirin Co Ltd

Common Name

Kyowa Kirin

Country

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

5,669

Ticker

4151

Exchange

TOKYO STOCK EXCHANGE

Website

www.kyowakirin.co.jp

Description

Kyowa Kirin Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and marketing of pharmaceuticals, biotechnology products, and medical devices. It... Show more

Financial Statements of Kyowa Kirin

Below are the financial statements of Kyowa Kirin, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of JPY	2024	2023
Non-current assets	—	—
Property, plant and equipment	111.48^a	94.51^a
Goodwill	181.03^a	140.45^a
Intangible assets	165.3^a	62.92^a
Investments accounted for using equity method	3.19^a	12.36^a
Other financial assets	32.8^a	33.37^a
Retirement benefit asset	19.78^a	15.66^a
Deferred tax assets	41.26^a	49.54^a
Other non-current assets	8.51^a	6.02^a
Total non-current assets	563.34^a	414.82^a
Current assets	—	—
Inventories	72.93^a	71.36^a
Trade and other receivables	157.02^a	119.08^a
Other financial assets	1.71^a	1.92^a
Other current assets	27.69^a	15.67^a
Cash and cash equivalents	244.68^a	403.08^a
Total current assets	504.03^a	611.12^a
Total assets	1,067.36^a	1,025.94^a
Equity	—	—
Share capital	26.75^a	26.75^a
Capital surplus	427.73^a	464.73^a
Treasury shares	-5.89^a	-2.93^a
Retained earnings	371.05^a	338.76^a
Other components of equity	31.17^a	9.11^a
Total equity attributable to owners of parent	850.81^a	836.42^a
Total equity	850.81^a	836.42^a
Non-current liabilities	—	—
Liabilities from application of equity method	11.7^a	13.97^a
Retirement benefit liability	0.27^a	0.29^a
Provisions	6.47^a	8.44^a
Deferred tax liabilities	0.43^a	0.43^a
Other financial liabilities	24.12^a	16.11^a
Other non-current liabilities	8.89^a	17.05^a
Total non-current liabilities	51.88^a	56.29^a
Current liabilities	—	—
Trade and other payables	121.06^a	92.98^a
Provisions	4.44^a	2.38^a
Other financial liabilities	4.63^a	8.14^a
Income taxes payable	3.38^a	4.02^a
Other current liabilities	31.16^a	25.72^a
Total current liabilities	164.68^a	133.24^a
Total liabilities	216.55^a	189.52^a
Total equity and liabilities	1,067.36^a	1,025.94^a

Verified Sources Behind Kyowa Kirin’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kyowa Kirin’s data sources below and access millions more through our Disclosure Search.

a. Kyowa Kirin's Financial Report 2024

Trace every data point back to Kyowa Kirin’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Kyowa Kirin Co Ltd

Financial Statements of Kyowa Kirin

Verified Sources Behind Kyowa Kirin’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Daiichi Sankyo Co Ltd

Astellas Pharma Inc

Chugai Pharmaceutical Co Ltd

Ono Pharmaceutical Co Ltd

Cosmos Pharmaceutical Corp

Shionogi & Co Ltd